Multiple myeloma
- PMID: 20159661
- PMCID: PMC2842171
- DOI: 10.1102/1470-7330.2010.0013
Multiple myeloma
Abstract
Advances in the imaging and treatment of multiple myeloma have occurred over the past decade. This article summarises the current status and highlights how an understanding of both is necessary for optimum management.
Similar articles
-
Whole-Body Imaging of Multiple Myeloma: Diagnostic Criteria.Radiographics. 2019 Jul-Aug;39(4):1077-1097. doi: 10.1148/rg.2019180096. Radiographics. 2019. PMID: 31283452 Review.
-
Imaging patients with myeloma.Clin Radiol. 2009 Jan;64(1):1-11. doi: 10.1016/j.crad.2008.07.006. Epub 2008 Aug 29. Clin Radiol. 2009. PMID: 19070692 Review.
-
Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.Clin Cancer Res. 2014 Dec 1;20(23):5888-97. doi: 10.1158/1078-0432.CCR-14-1692. Epub 2014 Oct 7. Clin Cancer Res. 2014. PMID: 25294899 Review.
-
The role of imaging techniques in the management of multiple myeloma.Br J Haematol. 2012 Dec;159(5):499-513. doi: 10.1111/bjh.12007. Epub 2012 Aug 11. Br J Haematol. 2012. PMID: 22881361 Review.
-
An Unusual Cause of a Pathological Vertebral Fracture: Solitary Plasmacytoma.Am J Med Sci. 2020 Aug;360(2):206-207. doi: 10.1016/j.amjms.2020.04.001. Epub 2020 Apr 11. Am J Med Sci. 2020. PMID: 32387118 No abstract available.
Cited by
-
Tris(dibenzylideneacetone)dipalladium(0) (Tris DBA) Abrogates Tumor Progression in Hepatocellular Carcinoma and Multiple Myeloma Preclinical Models by Regulating the STAT3 Signaling Pathway.Cancers (Basel). 2021 Oct 31;13(21):5479. doi: 10.3390/cancers13215479. Cancers (Basel). 2021. PMID: 34771643 Free PMC article.
-
Very late antigen-4 (α(4)β(1) Integrin) targeted PET imaging of multiple myeloma.PLoS One. 2013;8(2):e55841. doi: 10.1371/journal.pone.0055841. Epub 2013 Feb 8. PLoS One. 2013. PMID: 23409060 Free PMC article.
-
Imaginological characterization of multiple myeloma lesions of the jaws through cone-beam computed tomography.Oral Radiol. 2020 Apr;36(2):168-176. doi: 10.1007/s11282-019-00394-1. Epub 2019 Jun 19. Oral Radiol. 2020. PMID: 31222625
-
Predicting cytogenetic risk in multiple myeloma using conventional whole-body MRI, spinal dynamic contrast-enhanced MRI, and spinal diffusion-weighted imaging.Insights Imaging. 2024 Apr 10;15(1):106. doi: 10.1186/s13244-024-01672-1. Insights Imaging. 2024. PMID: 38597979 Free PMC article.
-
PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies.Cancers (Basel). 2022 Nov 30;14(23):5941. doi: 10.3390/cancers14235941. Cancers (Basel). 2022. PMID: 36497423 Free PMC article. Review.
References
-
- American Cancer Society. . Cancer facts and figures. 2007
-
- International Myeloma Working Group. . Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group. Br J Haematol. 2003;121:749–57. - PubMed
-
- Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer. 1975;36:842–54. doi:10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U. - DOI - PubMed
-
- Durie BGM, Kyle RA, Belch A, et al. Myeloma management guidelines, a consensus report from the Scientific Advisors of the International Myeloma Foundation. Haematol J. 2003;4:379–98. - PubMed
-
- Greipp PR, San Miguel J, Durie BG, et al. International staging system for myeloma. J Clin Oncol. 2005;23:3412–20. doi:10.1200/JCO.2005.04.242. PMid:15809451. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous